How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

This study is looking at how hormones and a type of therapy called Exposure and Response Prevention (EX/RP) affect the brains of people with Obsessive-Compulsive Disorder (OCD). EX/RP is a common treatment for OCD that involves facing your fears and not doing your usual rituals. Researchers want to see how hormones, especially during a woman's menstrual cycle, impact how well EX/RP works and how it changes the brain's fear network. You might be able to join if you are 18-45 years old, have an OCD diagnosis, and for women, are menstruating regularly. You also can't have taken certain medications recently. The study will measure changes in your brain using fMRI (a type of brain scan) and your OCD symptoms over about 4 weeks. The study's current status is unclear.

Study design
This is an interventional study planning to enroll 120 participants. Female participants will be randomly assigned to receive EX/RP during different phases of their menstrual cycles.
What's involved
Participants will complete neuroimaging (fMRI scans), provide samples for hormonal tests, and have their OCD symptoms rated before and after a brief 8-session course of EX/RP, which takes about 4 weeks.
Compensation
Not stated in the trial record.
Follow-up
OCD symptoms and fMRI changes will be measured at baseline and approximately 4 weeks later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05359562

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Recruiting
NAAges 18–45InterventionalTreatment
University of Pennsylvania
~120 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Exposure & Response Prevention (EX/RP)

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
fMRI
Measured over Baseline to approximately 4 weeks later
+1 more outcome measured
OCD
2 sites across 2 states
New York1
Pennsylvania1
  • Lily Brown, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Helen B Simpson, MD, PhD · PRINCIPAL_INVESTIGATOR · New York State Psychiatric Institute

Opens a ready-to-send draft in your own email app — review before sending.

  • fMRIBaseline to approximately 4 weeks later

    Slope of change in brain activation (fMRI)

  • OCD SymptomsBaseline to approximately 4 weeks later

    Slope of change in Obsessive Compulsive Symptom Severity (Yale-Brown Obsessive Compulsive Scale)